INNOVENT ANNOUNCES IBI3003 (GPRC5D/BCMA/CD3 TRISPECIFIC ANTIBODY) RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FDA FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Reuters · 01/27 00:00

Please log in to view news